Etova-MR Pregnancy

How do you administer this medicine?

Consists of etodolac, thiocolchicoside

Pregnancy of Etodolac (Etova-MR) in details

Pregnancy is always a special situation where every action or side effect of the drug varies when compared to a situation of a non-pregnant patient. It is not only because the pregnant woman's metabolism differs due to the hormonal and other changes happened to her, but also because every medicine or its metabolite passes to the baby and shows its action there. The only thing is, be cautious, attentive and well supervised when you take any single drug in pregnancy. The interactions can vary in pregnancy, and the dosage may differ as well. Strict supervision of the Physician is mandatory.

Etodolac (Etova-MR) has been assigned to pregnancy category C by the FDA. Skeletal anomalies (i.e. polydactyly, oligodactyly, syndactyly, unossified phalanges, synostosis of metatarsals) have been noted in some animal studies although a direct drug or dose response relationship could not be established. There are no controlled data in human pregnancy. Use late in pregnancy may result in premature closure of the ductus arteriosus and prolong labor and delivery. Etodolac (Etova-MR) should only be given during pregnancy when benefit outweighs risk. Etodolac (Etova-MR) should be avoided near term.

See references

Etodolac (Etova-MR) breastfeeding

When a drug is taken when the patient is breast feeding, a part of the drug is secreted in her breast milk and is passed to the baby. The dosage of the medicine to mother and baby are different, and many drugs actions are side effects when you take them without a disease, and what if you the baby takes them without a disease? What if the drug is contraindicated in newborns, infants or children? So, breastfeeding is a very alarming situation when the mother is on medications. Ask your Physician or Pediatrician about the effect of the drug on the baby and how much is excreted in breast milk and if it harms the baby!

There are no data on the excretion of Etodolac (Etova-MR) into human milk. However, trace amounts of some NSAIDs have been reported in human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Lodine (Etodolac (Etova-MR))." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  2. Koren G, Pastuszak A, Ito S "Drugs in pregnancy." N Engl J Med 338 (1998): 1128-37

References for breastfeeding information

  1. "Product Information. Lodine (Etodolac (Etova-MR))." Wyeth-Ayerst Laboratories, Philadelphia, PA.



  1. DailyMed. "ETODOLAC: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". (accessed September 17, 2018).
  2. PubMed Health. "Lodine: This section provide the link out information of drugs collectetd in PubMed Health. ". (accessed September 17, 2018).
  3. Human Metabolome Database (HMDB). "Etodolac: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". (accessed September 17, 2018).


Consumer reviews

There are no reviews yet. Be the first to write one!

Your name: 
Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 All Rights Reserved